Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated Recurrent Urinary Tract Infections (rUTIs) in Women

NCT07184827 is registered in ClinicalTrials.gov with TCM Biotech International Corp. as lead sponsor.

NCT NCT07184827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07184827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated Recurrent Urinary Tract Infections (rUTIs) in Women
Lead sponsor
TCM Biotech International Corp.
Phase
Phase 3
Overall status
Recruiting
Start date
October 14, 2020
Completion date
July 31, 2028
Enrollment
348 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent urinary tract infections in women